Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03340740 · ClinicalTrials.gov registry record · Phase 4
The Effect of Cetirizine on Bronchoconstriction
A Phase 4 study of Asthma and Allergic Rhinitis, sponsored by New York City Health and Hospitals Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03340740 is a Phase 4 study of Asthma and Allergic Rhinitis that has completed, run by New York City Health and Hospitals Corporation. The registered enrollment target is 40 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03340740, a Phase 4 study of Asthma and Allergic Rhinitis, has completed, sponsored by New York City Health and Hospitals Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effect of cetirizine, an oral antihistamine, on wheezing in patients with allergic rhinitis. Patients presenting to the pediatric emergency department who have a history of allergic rhinitis and who are wheezing will be asked to participate. Half of patients will receive a dose of cetirizine and the other half will receive placebo and their response will be monitored over the course of their emergency department visit with vital signs, physical examinations, and measurement of bronchoconstriction with spirometry.
Conditions Studied
Interventions
- DRUG Cetirizine Hydrochloride 1 MG/ML
- DRUG Placebo - Concentrate
Study Locations (1)
New York
- Jacobi Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-05-11 |
| Est. Completion | 2021-08-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03340740
The ClinicalTrials.gov registry entry for NCT03340740 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (97% lower). The listed sponsor is New York City Health and Hospitals Corporation, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Cetirizine Hydrochloride 1 MG/ML is the first listed.
NCT03340740 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03340740 about?
NCT03340740 is a clinical study titled "The Effect of Cetirizine on Bronchoconstriction". The purpose of this study is to determine the effect of cetirizine, an oral antihistamine, on wheezing in patients with allergic rhinitis. Patients presenting to the pediatric emergency department who have a history of allergic rhinitis and who are wheezing will be asked to participate. Half of pati...
What is the current status of trial NCT03340740?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2018-05-11. Estimated completion is 2021-08-30.
What conditions does trial NCT03340740 study?
This clinical trial studies the following conditions: Asthma, Allergic Rhinitis.
What interventions are being tested in trial NCT03340740?
The interventions under investigation include: Cetirizine Hydrochloride 1 MG/ML (DRUG), Placebo - Concentrate (DRUG).
Who is sponsoring clinical trial NCT03340740?
This trial is sponsored by New York City Health and Hospitals Corporation, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03340740 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
-
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 4
-
Viral Infection in Asthma (VIA) Study
RECRUITING · Phase 4
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
RECRUITING · Phase 4
-
The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)
RECRUITING · Phase 4
-
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.